StockNews.com Initiates Coverage on Aspira Women’s Health (NASDAQ:AWH)

Investment analysts at StockNews.com started coverage on shares of Aspira Women’s Health (NASDAQ:AWH) in a research note issued on Friday. The brokerage set a “hold” rating on the stock.

Aspira Women’s Health Stock Performance

AWH stock opened at $0.75 on Friday. The company has a fifty day moving average price of $0.83 and a 200-day moving average price of $1.12. The company has a market capitalization of $12.50 million, a P/E ratio of -0.62 and a beta of 1.39. Aspira Women’s Health has a 52-week low of $0.67 and a 52-week high of $5.65.

Institutional Investors Weigh In On Aspira Women’s Health

A hedge fund recently raised its stake in Aspira Women’s Health stock. B. Riley Wealth Advisors Inc. grew its holdings in shares of Aspira Women’s Health Inc. (NASDAQ:AWH) by 88.6% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 236,396 shares of the company’s stock after buying an additional 111,022 shares during the quarter. B. Riley Wealth Advisors Inc. owned 1.90% of Aspira Women’s Health worth $352,000 at the end of the most recent reporting period. Institutional investors own 12.19% of the company’s stock.

About Aspira Women’s Health

Aspira Women's Health Inc, together with its subsidiaries, discovers, develops, and commercializes of noninvasive AI-powered diagnostic tests for gynecologic diseases in the United States. The company's products include Ova1Plus, a qualitative serum test to assess the likelihood of malignancy in women with an ovarian adnexal mass; Overa, a biomarker test intended to maintain Ova1's high sensitivity; and OvaWatch, a laboratory developed tests to assist in the initial clinical assessment of malignancy risk in all women thought to have an indeterminate or benign adnexal mass.